BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 28, Issue 26
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review
©The Author(s) 2022.
World J Gastroenterol. Jul 14, 2022; 28(26): 3008-3026
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3008
Table 2 Sensitivity of common imaging modalities used in the evaluation of gastroenteropancreatic neuroendocrine neoplasms
Imaging modality
Sensitivity
Transabdominal USG13%-27% for GEPNEN
Contrast enhanced ultrasound99% in detecting liver metastases
Endoscopic ultrasonography 82%-93% for PNEN
CECT63%-82% for PNEN
CE MRI79% for PNEN
DWI83% for liver metastases
USG: Ultrasonography; GEPNEN: Gastroenteropancreatic neuroendocrine neoplasms; CECT: Contrast enhanced computed tomography; CE MRI: Contrast-enhanced magnetic resonance imaging; DWI: Diffusion-weighted imaging.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.